These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 16720984)
1. Review of pharmacokinetic, pharmacodynamic and clinical studies with a modern combination of amoxicillin/sulbactam. Soutric J; Bantar C; Caruso N; Heguilén R; Casellas JM; Casellas JM; Farinati A; Jasovich A; Arenoso H; Rodriguez M Chemotherapy; 2006; 52(4):200-4. PubMed ID: 16720984 [TBL] [Abstract][Full Text] [Related]
2. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains. Paniagua GL; Monroy E; García O; Vaca S Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741 [TBL] [Abstract][Full Text] [Related]
3. Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination. Wildfeuer A; Schmalreck A; Räder K; Eibel G; Pfaff G Arzneimittelforschung; 1989 Jan; 39(1):94-100. PubMed ID: 2785802 [TBL] [Abstract][Full Text] [Related]
4. Rational antibiotic therapy and the position of ampicillin/sulbactam. Lode HM Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004 [TBL] [Abstract][Full Text] [Related]
5. Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria. Lavigne JP; Bonnet R; Michaux-Charachon S; Jourdan J; Caillon J; Sotto A J Antimicrob Chemother; 2004 Apr; 53(4):616-9. PubMed ID: 14985275 [TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic assessment of Amoxicillin-Sulbactam against Acinetobacter baumannii: searching the optimal dose and infusion time through a human ex-vivo model. Bantar C; Canigia LF; Berger MA; Soutric JL; Arenoso HJ Braz J Infect Dis; 2009 Oct; 13(5):348-52. PubMed ID: 20428633 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of amoxicillin-sulbactam, a novel aminopenicillin-beta-lactamase inhibitor combination, against Escherichia coli. Bantar C; Nicola F; Arenoso HJ; Galas M; Soria L; Dana D; Rossi A; Bianchini H; Jasovich A Antimicrob Agents Chemother; 1999 Jun; 43(6):1503-4. PubMed ID: 10348782 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase]. Moittie D; Simonet M; Veron M Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and pharmacoeconomic perspective use of amoxicillin/sulbactam in the treatment of extra-hospital pneumonia]. Sinopal'nikov AI; Zaĭtsev AA Voen Med Zh; 2006 Nov; 327(11):42-5. PubMed ID: 17300060 [No Abstract] [Full Text] [Related]
10. Comparative activities in vitro of amoxycillin/clavulanic acid and ampicillin/sulbactam. Masters PJ; Cooper CE; Griffin KE; Slocombe B; Sutherland R J Chemother; 1989 Jul; 1(4 Suppl):67-9. PubMed ID: 16312307 [No Abstract] [Full Text] [Related]
11. [Pharmacological studies of sulbactam and its association with semisynthetic beta-lactam antibiotics]. Nechifor M; Buiuc D; Diaconu E; Poiată A; Teslariu E; Filip C; Negru A; Antonescu C Rev Med Chir Soc Med Nat Iasi; 1992; 96(1-2):51-5. PubMed ID: 1410925 [TBL] [Abstract][Full Text] [Related]
12. [Amoxycillin/Sulbactam (Trifamox IBL) in prophylaxis and therapy of surgical site infections in oncologic patients]. Mitrokhin SD; Sokolov AA Antibiot Khimioter; 2010; 55(7-8):34-41. PubMed ID: 21140563 [No Abstract] [Full Text] [Related]
13. [Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam]. Barcelona L; Marín M; Stamboulian D Medicina (B Aires); 2008; 68(1):65-74. PubMed ID: 18416324 [TBL] [Abstract][Full Text] [Related]
15. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid]. Villar HE; Jugo MB; Fernández-Lausi A; Farinati AE Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of cefoperazone-sulbactam: Singapore experience. Kumarasinghe G; Chow C; Chiu C; Cheong YM Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):734-7. PubMed ID: 9253876 [TBL] [Abstract][Full Text] [Related]
17. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections. Betrosian AP; Douzinas EE Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991 [TBL] [Abstract][Full Text] [Related]